Accueil   Diary - News   All news bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system

bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system

Marcy l’Étoile (France) - April 6, 2017 – bioMérieux, a major player in the field of in vitro diagnostics, and the world leader in microbiology, announces that BacT/ALERT® VIRTUO™, its fully automated blood culture system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This innovative blood culture microbial detection system is now commercially available in countries that recognize CE marking and in the United States.

 

 

 

 

Read the press release